Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 2
2004 1
2005 2
2006 4
2007 8
2008 4
2009 1
2010 3
2011 13
2012 10
2013 10
2014 5
2015 14
2016 14
2017 13
2018 14
2019 17
2020 33
2021 61
2022 49
2023 28
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

264 results

Results by year

Filters applied: . Clear all
Page 1
Image Guided Intraoperative Radiation Therapy After Surgical Resection of Brain Metastases: A First In-Human Feasibility Report.
Grimmer M, Sarria GR, Hamed M, Banat M, Kugel F, Lorenzana H, Scafa D, Köksal M, Layer JP, Dejonckheere C, Fiebich M, Schmeel FC, Kowark A, Vatter H, Schmeel LC, Garbe S. Grimmer M, et al. Among authors: vatter h. Adv Radiat Oncol. 2024 Feb 5;9(5):101466. doi: 10.1016/j.adro.2024.101466. eCollection 2024 May. Adv Radiat Oncol. 2024. PMID: 38550377 Free PMC article.
Synchronous versus metachronous spinal metastasis: a comparative study of survival outcomes following neurosurgical treatment.
Banat M, Potthoff AL, Hamed M, Borger V, Scorzin JE, Lampmann T, Asoglu H, Khalafov L, Schmeel FC, Paech D, Radbruch A, Nitsch L, Weller J, Herrlinger U, Toma M, Gielen GH, Vatter H, Schneider M. Banat M, et al. Among authors: vatter h. J Cancer Res Clin Oncol. 2024 Mar 19;150(3):136. doi: 10.1007/s00432-024-05657-x. J Cancer Res Clin Oncol. 2024. PMID: 38502313 Free PMC article.
Defining benchmark outcomes for mesial temporal lobe epilepsy surgery: A global multicenter analysis of 1119 cases.
Drexler R, Ricklefs FL, Ben-Haim S, Rada A, Wörmann F, Cloppenborg T, Bien CG, Simon M, Kalbhenn T, Colon A, Rijkers K, Schijns O, Borger V, Surges R, Vatter H, Rizzi M, de Curtis M, Didato G, Castelli N, Carpentier A, Mathon B, Yasuda CL, Cendes F, Chandra PS, Tripathi M, Clusmann H, Delev D, Guenot M, Haegelen C, Catenoix H, Lang J, Hamer H, Brandner S, Walther K, Hauptmann JS, Jeffree RL, Kegele J, Weinbrenner E, Naros G, Velz J, Krayenbühl N, Onken J, Schneider UC, Holtkamp M, Rössler K, Spyrantis A, Strzelczyk A, Rosenow F, Stodieck S, Alonso-Vanegas MA, Wellmer J, Wehner T, Dührsen L, Gempt J, Sauvigny T. Drexler R, et al. Among authors: vatter h. Epilepsia. 2024 Feb 24. doi: 10.1111/epi.17923. Online ahead of print. Epilepsia. 2024. PMID: 38400789
Multicentric Assessment of Safety and Efficacy of Combinatorial Adjuvant Brain Metastasis Treatment by Intraoperative Radiation Therapy and Immunotherapy.
Layer JP, Shiban E, Brehmer S, Diehl CD, de Castro DG, Hamed M, Dejonckheere CS, Cifarelli DT, Friker LL, Herrlinger U, Hölzel M, Vatter H, Schneider M, Combs SE, Schmeel LC, Cifarelli CP, Giordano FA, Sarria GR, Kahl KH. Layer JP, et al. Among authors: vatter h. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1552-1562. doi: 10.1016/j.ijrobp.2024.01.009. Epub 2024 Jan 9. Int J Radiat Oncol Biol Phys. 2024. PMID: 38199383 Free article.
Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes.
Dejonckheere CS, Layer JP, Hamed M, Layer K, Glasmacher A, Friker LL, Potthoff AL, Zeyen T, Scafa D, Koch D, Garbe S, Holz JA, Kugel F, Grimmer M, Schmeel FC, Gielen GH, Forstbauer H, Vatter H, Herrlinger U, Giordano FA, Schneider M, Schmeel LC, Sarria GR. Dejonckheere CS, et al. Among authors: vatter h. J Neurooncol. 2023 Sep;164(3):683-691. doi: 10.1007/s11060-023-04464-7. Epub 2023 Oct 9. J Neurooncol. 2023. PMID: 37812290 Free PMC article.
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial.
Weller J, Zeyen T, Schäfer N, Schaub C, Potthoff AL, Steinbach JP, Hau P, Seidel C, Goldbrunner R, Tabatabai G, Vatter H, Tzaridis T, Schneider M, Herrlinger U. Weller J, et al. Among authors: vatter h. J Neurooncol. 2023 Sep;164(3):749-755. doi: 10.1007/s11060-023-04470-9. Epub 2023 Oct 3. J Neurooncol. 2023. PMID: 37787906 Free PMC article.
264 results